Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN(®)) and Follow-Up Considerations/Recommendations

Current management of diabetic macular edema (DME) predominantly involves treatment with short-acting intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) and/or corticosteroids; however, short-acting therapies (lasting between 1 and 6 months) require frequent injections...

Descripción completa

Detalles Bibliográficos
Autores principales: Adán, Alfredo, Cabrera, Francisco, Figueroa, Marta S, Cervera, Enrique, Ascaso, Francisco J, Udaondo, Patricia, Abraldes, Maximino, Reyes, Miguel Ángel, Pazos, Marta, Pessoa, Bernardete, Armadá, Félix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398681/
https://www.ncbi.nlm.nih.gov/pubmed/32801618
http://dx.doi.org/10.2147/OPTH.S252359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398681/
https://www.ncbi.nlm.nih.gov/pubmed/32801618
http://dx.doi.org/10.2147/OPTH.S252359

Ejemplares similares